tiprankstipranks
Trending News
More News >
medmix AG (CH:MEDX)
:MEDX
Switzerland Market

medmix AG (MEDX) AI Stock Analysis

Compare
0 Followers

Top Page

medmix AG (MEDX) vs. iShares MSCI Switzerland ETF (EWL)

medmix AG Business Overview & Revenue Model

Company Description
How the Company Makes Money

medmix AG Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
479.70M483.90M486.60M477.10M457.30M351.30M
Gross Profit
156.30M159.70M157.70M175.40M181.20M121.10M
EBIT
14.00M12.90M16.00M19.60M59.90M18.10M
EBITDA
75.70M67.30M71.40M68.30M110.60M60.90M
Net Income Common Stockholders
-1.80M-7.40M300.00K11.60M44.00M9.60M
Balance SheetCash, Cash Equivalents and Short-Term Investments
79.30M96.20M130.60M316.80M210.00M46.20M
Total Assets
697.00M954.20M1.01B1.11B974.40M789.90M
Total Debt
276.60M323.40M349.70M473.50M320.90M332.30M
Net Debt
272.10M227.20M219.10M160.00M111.10M317.50M
Total Liabilities
401.90M507.50M532.40M601.10M440.50M456.50M
Stockholders Equity
295.10M436.40M465.40M504.80M533.90M333.40M
Cash FlowFree Cash Flow
19.20M38.10M3.20M9.00M55.40M7.50M
Operating Cash Flow
69.30M86.60M56.10M47.60M87.30M50.60M
Investing Cash Flow
-88.60M-51.50M-80.60M-57.00M-3.30M4.40M
Financing Cash Flow
15.20M-48.60M-153.80M116.10M111.60M-42.90M

medmix AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
CHF436.56M
4.72%
75
Outperform
CHF613.65M7.87
32.30%631.04%
54
Neutral
$5.31B3.28-45.10%2.80%16.76%0.02%
$3.28B41.4320.81%0.48%
$2.56B32.914.84%1.74%
DE283
€365.97M16.5413.13%2.29%
CHMED
CHF1.05B289.13
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:MEDX
medmix AG
10.58
-4.48
-29.75%
CH:BSLN
Basilea Pharmaceutica
50.40
8.55
20.43%
MEDGF
Medacta Group SA
164.03
22.89
16.22%
TCHBF
Tecan Group AG
198.08
-144.81
-42.23%
DE:283
IVF HARTMANN Holding AG
148.00
18.66
14.43%
CH:MED
Medartis Holding AG
77.40
0.60
0.78%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.